These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 31504268)

  • 1. Non-coding RNA in endothelial-to-mesenchymal transition.
    Hulshoff MS; Del Monte-Nieto G; Kovacic J; Krenning G
    Cardiovasc Res; 2019 Oct; 115(12):1716-1731. PubMed ID: 31504268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases.
    Jackson AO; Zhang J; Jiang Z; Yin K
    Trends Cardiovasc Med; 2017 Aug; 27(6):383-393. PubMed ID: 28438397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial to mesenchymal transition in the cardiovascular system.
    Gong H; Lyu X; Wang Q; Hu M; Zhang X
    Life Sci; 2017 Sep; 184():95-102. PubMed ID: 28716564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology.
    Singh A; Bhatt KS; Nguyen HC; Frisbee JC; Singh KK
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation of Endothelial-to-Mesenchymal Transition in Chronic Heart Disease.
    Hulshoff MS; Xu X; Krenning G; Zeisberg EM
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1986-1996. PubMed ID: 30354260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promising field: regulating imbalance of EndMT in cardiovascular diseases.
    Zhou K; Tian KJ; Yan BJ; Gui DD; Luo W; Ren Z; Wei DH; Liu LS; Jiang ZS
    Cell Cycle; 2021 Aug; 20(15):1477-1486. PubMed ID: 34266366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
    Sharma V; Dogra N; Saikia UN; Khullar M
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.
    Cheng W; Li X; Liu D; Cui C; Wang X
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):3-11. PubMed ID: 32851865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
    Gorelova A; Berman M; Al Ghouleh I
    Antioxid Redox Signal; 2021 Apr; 34(12):891-914. PubMed ID: 32746619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.
    Sánchez-Duffhues G; García de Vinuesa A; Ten Dijke P
    Dev Dyn; 2018 Mar; 247(3):492-508. PubMed ID: 28891150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y; Zhou X; Hu R; Dai A
    Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition.
    Chen PY; Simons M
    Curr Drug Targets; 2016; 17(15):1707-1713. PubMed ID: 27138761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular Diseases.
    Anbara T; Sharifi M; Aboutaleb N
    Curr Cardiol Rev; 2020; 16(4):306-314. PubMed ID: 31393254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular and Cellular Aspects of the Endothelial-Mesenchymal Transition in Cardiovascular Diseases].
    Strelnikova EA; Kalinin RE; Suchkov IA; Korotkova NV; Mzhavanadze ND
    Mol Biol (Mosk); 2023; 57(4):563-572. PubMed ID: 37528777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis.
    Wesseling M; Sakkers TR; de Jager SCA; Pasterkamp G; Goumans MJ
    Vascul Pharmacol; 2018 Jul; 106():1-8. PubMed ID: 29471141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation.
    Wang E; Chen S; Wang H; Chen T; Chakrabarti S
    Cardiovasc Diabetol; 2023 Nov; 22(1):303. PubMed ID: 37924123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-mesenchymal transition in atherosclerosis.
    Souilhol C; Harmsen MC; Evans PC; Krenning G
    Cardiovasc Res; 2018 Mar; 114(4):565-577. PubMed ID: 29309526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y; Zhang Y; Tang Y; Li Q
    Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and Circulating Endothelial Cells Undergo Endothelial to Mesenchymal Transition (EndMT) in Response to Musculoskeletal Injury.
    Agarwal S; Loder S; Cholok D; Peterson J; Li J; Fireman D; Breuler C; Hsieh HS; Ranganathan K; Hwang C; Drake J; Li S; Chan CK; Longaker MT; Levi B
    Sci Rep; 2016 Sep; 6():32514. PubMed ID: 27616463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.